Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2023; 13(12): 184-189


An LC–MS/MS method development and validation for the determination of clomiphene in biological matrices

Vinayaga Sundaram Krishnan, Bhikshapathi Darna.




Abstract
Cited by 0 Articles

A specific, linear, and precise liquid chromatography—tandem mass spectrometry procedure was established and subjected to the validation for the quantitation of clomiphene in plasma sample. YMC-Pack C18-AM (3μm; 4.6 mm i.d × 50 mm) stationary phase was utilized to achieve chromatography elution, through a flowing rate of 0.70 ml/minute. Isocratic elution was done using methanol, acetonitrile, and 0.10% V/V HCOOH in a fraction of 70:15:15 as the mobile phasic system. For clomiphene and nilotinib separation, liquid–liquid extraction method was carried out utilizing ethyl acetate as solvent. A triple quadrupole mass detector was employed for the quantification of ions. Electrospray ionization in a positive ionizing method, which was executed in multiple reaction monitoring with parent/product ionic transitions m/z 406.18→100.11 for clomiphene and 530.70→289.50 for nilotinib internal standard. A calibration graph was executed between the concentrations of 12.5–500.0 ng/ml and the resulting equation was y = 0.00413x – 0.00854 with an r2 value of more than 0.99. Clomiphene recovery values were found more than 95.82% and its accuracy measured in terms of relative error was in the range 3.25%–4.79%. Accuracy findings, sensitivity and recovery values of clomiphene in the sample plasma for the established technique evidences its importance in pharmacokinetic and bioequivalence study.

Key words: LC–MS/MS, Clomiphene, Ovulation, Validation, Accuracy and Linearity.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.